PT Millennium Pharmacon International Tbk reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was IDR 2,393,386.78 million compared to IDR 2,271,429.69 million a year ago. Net income was IDR 23,841.74 million compared to IDR 10,013.41 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
138 IDR | -0.72% | -1.43% | -12.66% |
1st Jan change | Capi. | |
---|---|---|
-12.66% | 10.82M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- SDPC Stock
- News PT Millennium Pharmacon International Tbk
- PT Millennium Pharmacon International Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022